Fridge-free drugs, global markets: How AFT are targeting a $6 billion opportunity

Welcome to the HotCopper Watchlist, where today we’ve spoken to AFT Pharmaceuticals (ASX:AFP) chief and founder Hartley Atkinson to discuss R&D on a “promising” new product and entry into the Canadian stock market.

Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.

Disclaimer: This content has been prepared as part of an ongoing partnership with AFT Pharma Ltd and is intended for informational purposes only.

“There’s a problem nowadays where there’s a real deluge of drugs that are stored in the fridge, not just vaccines but standard hospital drugs, too. What this does is it offers us an opportunity to develop drugs that don’t have to be stored in the fridge using tech from the U.K.,” Mr Atkinson told The Market Link.

He continued: “You know, this will be much, much simpler for hospitals and certainly it would be commercially attractive for them as well.”

You can watch the full AFP interview in the browser above.

Join the discussion. See what HotCopper users are saying about AFT Pharma Ltd and be part of the conversations that move the markets.

The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.